Adam Boxer

MD PhD

Neurologist
International leader in treating atypical parkinsonism

About me

Dr. Adam Boxer is a neurologist at the UCSF Memory and Aging Center who specializes in Alzheimer's disease, frontotemporal dementia and atypical parkinsonism – in particular, corticobasal degeneration and progressive supranuclear palsy.

Boxer obtained his medical and doctoral degrees as part of the Medical Scientist Training Program at New York University School of Medicine, a program funded by the National Institutes of Health. He completed a residency in neurology at Stanford University Medical Center and a fellowship in behavioral neurology at UCSF.

Boxer directs the clinical neurology research unit for the Sandler Neurosciences Center at Mission Bay, as well as the clinical trials program for Alzheimer's disease and frontotemporal dementia at the Memory and Aging Center.

Boxer received the Edwin Boldrey Award from the San Francisco Neurological Society in 2002 for basic research in neurological disease, the 2005 John Douglas French Alzheimer's Foundation Alzheimer's Award and a 2009 Hellman Family Foundation fellowship.

  • Education

    New York University School of Medicine, 1998

  • Residencies

    Stanford Hospital and Clinics, 2002

  • Academic Title

    Professor

We empower patients and their families to access cutting-edge diagnostic and therapeutic technologies for neurodegenerative diseases of aging.

Conditions I specialize in

Memory and Aging Center

1500 Owens St., Suite 320
San Francisco, CA 94158

(415) 353-2057
M-F, 8 a.m. - 5 p.m.

Selected research

Decorative Caduceus

4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

The goal of this study is to identify the most reliable methods of analysis for tracking CBD, PSP, and o/vPSP over time. The results from this study may be used in the future to calculate statistical power for clinic...

Recruiting

Decorative Caduceus

Intranasal Oxytocin for Frontotemporal Dementia

The purpose of this study is to assess the safety, tolerability and effects on behaviour of Syntocinon given intranasally (by a spray into the nostrils) compared to placebo (an inactive saline substance that contains...

Recruiting

Decorative Caduceus

Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)

Frontotemporal Lobar Degeneration (FTLD) is the neuropathological term for a collection of rare neurodegenerative diseases that correspond to four main overlapping clinical syndromes: frontotemporal dementia (FTD), p...

Recruiting

Decorative Caduceus

Salsalate in Patients Mild to Moderate Alzheimer's Disease

The purpose of the study is to test the safety and tolerability of twice daily Salsalate in patients with mild to moderate Alzheimer's Disease. Half of the participants will receive Salsalate and half will receive pl...

Recruiting

Contact me

Providers on my team

Share